NORD and 70 other organizations urge Senate HELP and House Energy and Commerce leadership to address clinical trial diversity in the PDUFA reauthorization
Published: Jul 11, 2022
Tagged in: Clinical Trials, User Fee Act
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD and 70 other organizations urge Senate HELP and House Energy and Commerce leadership to address clinical trial diversity in the PDUFA reauthorization
Published: Jul 11, 2022
Tagged in: Clinical Trials, User Fee Act
NORD and 21 organizations send letter to House Energy and Commerce Committee leadership to support the NIH Clinical Trial Diversity Act
Published: Jun 9, 2022
Tagged in: Clinical Trials, Rare Disease Clinical Trials
NORD and 71 organizations urge Senate HELP committee to incorporate Title V in the House PDUFA bill
Published: Jun 8, 2022
Tagged in: User Fee Act, Clinical Trials